Status:

COMPLETED

Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial

Lead Sponsor:

Espen A. Haavardsholm

Collaborating Sponsors:

The Research Council of Norway

Smerud Medical Research International AS

Conditions:

Rheumatoid Arthritis

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

The ultimate goal of treatment in early rheumatoid arthritis (RA) is remission, i.e. an absence of signs and symptoms of the disease. However, the optimal way of reaching this goal is not known. Ultr...

Eligibility Criteria

Inclusion

  • Inclusion criteria (all):
  • Male or non-pregnant, non-nursing female
  • \> 18 years of age and \< 75 years of age
  • Patients classified as having RA (according to new ACR/EULAR criteria)
  • Disease duration less than 2 years (defined as time from 1st joint swelling)
  • The treating rheumatologist decides the patient requires treatment with a Disease Modifying Anti-Rheumatic Drug (DMARD)
  • The patient has taken no prior DMARD
  • Patients able and willing to give written informed consent and comply with the requirements of the study protocol
  • Exclusion Criteria (any):
  • Abnormal renal function (serum creatinine \> 142 µmol/L in female and \> 168 µmol/L in male)
  • Abnormal liver function, active or recent hepatitis, cirrhosis
  • Major co-morbidities like severe malignancies, severe diabetic mellitus, severe infections, uncontrollable hypertension, severe cardiovascular disease and/or severe respiratory diseases.
  • Leukopenia and/or thrombocytopenia
  • Inadequate birth control conception, pregnancy, and/or breastfeeding
  • Indications of active tuberculosis
  • Psychiatric or mental disorders, alcohol abuse or other abuse of substances, language barriers or other factors which makes adherence to the study protocol impossible

Exclusion

    Key Trial Info

    Start Date :

    September 1 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 1 2015

    Estimated Enrollment :

    238 Patients enrolled

    Trial Details

    Trial ID

    NCT01205854

    Start Date

    September 1 2010

    End Date

    April 1 2015

    Last Update

    April 16 2015

    Active Locations (11)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 3 (11 locations)

    1

    Helse Bergen HF, Haukeland University Hospital, Dept. of Rheumatology

    Bergen, Bergen, Norway, 5021

    2

    Martina Hansens Hospital AS

    Sandvika, Bærum, Norway, 1306

    3

    Vestre Viken HF, Dept. of Rheumatology

    Drammen, Drammen, Norway, 3004

    4

    Sykehuset Østfold HF, Dept. of Rheumatology

    Moss, Fredrikstad, Norway, 1603